A. Gimenez-Roqueplo
Cell · 2005–2018
A researcher in the Science corpus: 11 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from A. Gimenez-Roqueplo's perspective
Ordered by how strongly the researchers A. Gimenez-Roqueplo trusts endorse each paper. Same corpus, a different order for every researcher.
- Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. (Science)
- A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. (Journal of Clinical Endocrinology and Metabolism)
- Genetic testing in pheochromocytoma or functional paraganglioma. (Journal of Clinical Oncology)
- Grading quality of evidence and strength of recommendations (British medical journal)
- Pathology and genetics of tumours of endocrine organs
- Hallmarks of cancer: the next generation. (Cell)
- Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis (Nucleic Acids Research)
- Comprehensive analysis of CpG islands in human chromosomes 21 and 22 (Proceedings of the National Academy of Sciences of the United States of America)
- The clinically inapparent adrenal mass: update in diagnosis and management. (Endocrine reviews)
- Early detection: The power and the promise of DNA methylation markers (Nature Reviews. Cancer)
Their papers
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) — 792 citations
- Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) — 2,007 citations
- Pathogenic germline variants in 10,389 adult cancers (2018) — 734 citations
- Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) — 2,663 citations
- Comprehensive molecular characterization of pheochromocytoma and paraganglioma (2017) — 670 citations
- A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. (2016) — 809 citations
- Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. (2014) — 2,500 citations
- SDH mutations establish a hypermethylator phenotype in paraganglioma. (2013) — 729 citations
- SDHA is a tumor suppressor gene causing paraganglioma. (2010) — 670 citations
- Pheochromocytoma: recommendations for clinical practice from the First International Symposium (2007) — 647 citations
- Genetic testing in pheochromocytoma or functional paraganglioma. (2005) — 664 citations